Stocks making big moves this week: Sprout Social, Redwire, Inspire Medical Systems, Fastly, and Marvell Technology

Sprout Social (SPT) fell 6.2% after Q3 2026 results and Q4 guidance missed estimates. Redwire (RDW) dropped 19.4% on Q3 revenue below expectations. Inspire Medical (INSP) declined 8.2% after a Q3 loss and narrowed FY guidance. Fastly (FSLY) fell 24.9% on Q3 results. Marvell (MRVL) dropped 8.8% after announcing a $115B Lumentum acquisition.

Original reporting
Published Nov 6, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 3:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stocks making big moves this week: Sprout Social, Redwire, Inspire Medical Systems, Fastly, and Marvell Technology — source image
Decision brief

The 30-second read

$SPTBearishLow
01

Why it matters

Each listed company experienced a notable price decline driven by fresh, material information disclosed on the same day.

02

Market read

The collective moves signal heightened risk for mid‑cap tech stocks after a series of disappointing earnings and a large acquisition.

03

What to watch

Potential hidden upside from cost‑cutting measures or long‑term strategic benefits of Marvell's acquisition.

Relevance 4/10Novelty 4/10Timing: same‑day reaction

Background

The article is a weekly roundup highlighting stocks that moved sharply after releasing earnings, guidance, or deal news.

Company-level read

Ticker impact

$SPTBearishHigh confidence
Context

Sprout Social fell 6.2% after reporting Q3 results and weak Q4 revenue guidance.

Expected impact

likely pressure as the market prices in the below‑estimate guidance

Evidence & confidence

Guidance miss is a fresh catalyst driving the decline.

$RDWBearishHigh confidence
Context

Redwire slid 19.4% after its Q3 revenue came in below analyst estimates.

Expected impact

likely pressure as investors react to the revenue shortfall

Evidence & confidence

The revenue miss is a new, material piece of information.

$INSPBearishHigh confidence
Context

Inspire Medical Systems dropped 8.2% after reporting a Q3 net loss of $24.4 million and narrowing full‑year revenue guidance.

Expected impact

likely pressure as the market digests the loss and guidance cut

Evidence & confidence

Both loss and guidance reduction are fresh, material data.

$FSLYBearishHigh confidence
Context

Fastly fell 24.9% after its Q3 2026 results failed to impress investors.

Expected impact

likely pressure as the market reacts to the weak earnings

Evidence & confidence

The earnings miss is a primary, material disclosure.

$MRVLBearishHigh confidence
Context

Marvell Technology dropped 8.8% after announcing an all‑stock acquisition of Lumentum valued at $115 billion.

Expected impact

likely pressure as investors assess the large‑scale deal

Evidence & confidence

The massive M&A announcement is a fresh, material event.

Market effects

Broad tech and aerospace sectors see heightened volatility from multiple earnings misses and a large M&A deal.

U.S. equity markets face downward pressure across mid‑cap tech names.

Limited to U.S. listed companies; no immediate global macro effect.

Counterpoint

Some investors may view the price drops as buying opportunities if fundamentals remain sound.

Key entities

  • Sprout Social

    Social media management platform

  • Redwire

    Aerospace and defense firm

  • Inspire Medical Systems

    Medical technology company

  • Fastly

    Edge cloud platform provider

  • Marvell Technology

    Networking chips designer

Related articles

$MRVLHighAI 9/10

Why Marvell Technology Stock Fell Hard in October

Marvell Technology (MRVL) shares fell 25.6% in October due to AI sector concerns and acquisition news. The company projected strong revenue growth but faced investor skepticism over AI spending and a potential $115B all-stock deal for Lumentum. Shares rebounded slightly in early November.

$MRVLHighAI 9/10

Marvell Sinks 36%, Lumentum Drops 31% on $115 Billion Deal: Is the Selloff Overdone?

Marvell Technology (MRVL) shares fell 36% and Lumentum (LITE) dropped 31% between October 28 and November 4 due to investor concerns over their proposed $115 billion all-stock acquisition. Lumentum shareholders would receive 4.5 Marvell shares per share, initially a 23.9% premium. The deal would increase Marvell's shares by 49%, raising dilution concerns. Marvell traded at 30x forward earnings, below its 5-year average of 33x.

$RDWMedAI 8/10

Redwire Q3 Earnings Call Highlights

Redwire (RDW) reported Q3 R&D expenses rose to $14.4M. Backlog hit $619.7M, up 14.3% sequentially. Reaffirmed 2026 revenue outlook of $450M-$500M. Secured $20M DARPA, $15M AscendArc, and $13.8M U.S. National Guard contracts. Ended Q3 with $538.9M liquidity and $47.8M debt.

$MRVLHighAI 9/10

Why Marvell Technology Stock Plunged 28.1% This Week

Marvell Technology (MRVL) fell 28.1% this week after announcing a $115 billion all-stock deal to acquire Lumentum (LITE). The acquisition, valued at a significant premium, raised dilution concerns, leading to downgrades from analysts. Marvell's stock is down 57.2% from its 52-week high, and the deal faces regulatory hurdles and potential channel conflicts.